A 31-month-old girl with fever, diarrhea, abdominal distension, and edemaLAMONT, J. T; RASHID, A.The New England journal of medicine. 1994, Vol 330, Num 6, pp 420-426, issn 0028-4793Article

Effect of purified Clostridium difficile toxins on intestinal smooth muscle. II: Toxin BGILBERT, R. J; POTHOULAKIS, C; LAMONT, J. T et al.American journal of physiology. Gastrointestinal and liver physiology. 1989, Vol 19, Num 4, pp G767-G772, issn 0193-1857Article

Colorectal cancer: risk factors and screening strategiesMOORE, J. R. L; LAMONT, J. T.Archives of internal medicine (1960). 1984, Vol 144, Num 9, pp 1819-1823, issn 0003-9926Article

Toxic megacolonSHETH, S. G; LAMONT, J. T.Lancet (British edition). 1998, Vol 351, Num 9101, pp 509-513, issn 0140-6736Article

Clostridium difficile colitisKELLY, C. P; POTHOULAKIS, C; LAMONT, J. T et al.The New England journal of medicine. 1994, Vol 330, Num 4, pp 257-262, issn 0028-4793Article

Clostridium difficile infectionKELLY, C. P; LAMONT, J. T.Annual review of medicine. 1998, Vol 49, pp 375-390, issn 0066-4219Article

Treatment of gastrointestinal infectionsBANERJEE, S; LAMONT, J. T.Gastroenterology (New York, NY. 1943). 2000, Vol 118, Num 2, pp S48-S67, issn 0016-5085, SUP1Article

Identification of gallbladder mucin-bilirubin complex in human cholesterol gallstone matrix: effects of reducing agents on in vitro dissolution of matrix and intact gallstonesSMITH, B. F; LAMONT, J. T.The Journal of clinical investigation. 1985, Vol 76, Num 2, pp 439-445, issn 0021-9738Article

Clostridium difficile colitis: epidemiology, pathophysiology, and treatmentMITTY, R. D; LAMONT, J. T.The Mount Sinai journal of medicine. 1994, Vol 61, Num 4, pp 329-335, issn 0027-2507Article

Clostridium difficile colitisTRNKA, Y. M; LAMONT, J. T.Advances in internal medicine. 1984, Vol 29, pp 85-107, issn 0065-2822Article

Bovine gallbladder mucin binds bilirubin in vitroSMITH, B. F; LAMONT, J. T.Gastroenterology (New York, NY. 1943). 1983, Vol 85, Num 3, pp 707-712, issn 0016-5085Article

Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosaCASTAGLIUOLO, I; RIEGLER, M. F; VALENICK, L et al.Infection and immunity. 1999, Vol 67, Num 1, pp 302-307, issn 0019-9567Article

Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tractKELLY, C. P; CHETHAM, S; KEATES, S et al.Antimicrobial agents and chemotherapy. 1997, Vol 41, Num 2, pp 236-241, issn 0066-4804Article

Involvement of ras-related rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin BDILLON, S. T; RUBIN, E. J; YAKUBOVICH, M et al.Infection and immunity. 1995, Vol 63, Num 4, pp 1421-1426, issn 0019-9567Article

Ketotifen inhibits Clostridium difficile toxin A : induced enteritis in rat ileumPOTHOULAKIS, C; KARMELI, F; KELLY, C. P et al.Gastroenterology (New York, NY. 1943). 1993, Vol 105, Num 3, pp 701-707, issn 0016-5085Article

Clostridium difficile toxin B disrupts the barrier fucntion of T₈₄ monolayersHECHT, G; KOUTSOURIS, A; POTHOULAKIS, C et al.Gastroenterology (New York, NY. 1943). 1992, Vol 102, Num 2, pp 416-423, issn 0016-5085Article

Bile salts stimulate glycoprotein release by guinea pig gallbladder in vitroO'LEARNY, D. P; MURRAY, F. E; TURNER, B. S et al.Hepatology (Baltimore, Md.). 1991, Vol 13, Num 5, pp 957-961, issn 0270-9139, 5 p.Article

C. difficile toxin A increases intestinal permeability and induces Cl^- secretionMOORE, R; POTHOULAKIS, C; LAMONT, J. T et al.American journal of physiology. Gastrointestinal and liver physiology. 1990, Vol 22, Num 2, pp G165-G172, issn 0193-1857Article

Dysphagia lusoria associated with an esophageal carcinomaLAZAR, H. L; MCCORMICK, J. R; LAMONT, J. T et al.The Annals of thoracic surgery. 1987, Vol 44, Num 3, pp 315-317, issn 0003-4975Article

Clostridium difficile toxin A causes early damage to mitochondria in cultured cellsHE, D; HAGEN, S. J; POTHOULAKIS, C et al.Gastroenterology (New York, NY. 1943). 2000, Vol 119, Num 1, pp 139-150, issn 0016-5085Article

Bovine immunoglobulin concentrate-Clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestineWARNY, M; FATIMI, A; BOSTWICK, E. F et al.Gut. 1999, Vol 44, Num 2, pp 212-217, issn 0017-5749Article

Intravenous immunoglobulin therapy for severe Clostridium difficile colitisSALCEDO, J; KEATES, S; POTHOULAKIS, C et al.Gut. 1997, Vol 41, Num 3, pp 366-370, issn 0017-5749Article

Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbitKELLY, C. P; BECKER, S; LINEVSKY, J. K et al.The Journal of clinical investigation. 1994, Vol 93, Num 3, pp 1257-1265, issn 0021-9738Article

Profound increase in viscosity and aggregation of pig gastric mucin at low pHBHASKAR, K. R; GONG, D; BANSIL, R et al.American journal of physiology. Gastrointestinal and liver physiology. 1991, Vol 24, Num 5, pp G827-G832, issn 0193-1857Article

Mono-, di- and trimethylamine in human gastric fluid: potential substrates for nitrosodimethylamine formationZEISEL, S. H; DACOSTA, K. A; LAMONT, J. T et al.Carcinogenesis (New York. Print). 1988, Vol 9, Num 1, pp 179-181, issn 0143-3334Article